Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | MPO | P05164 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.67 |
| ▸ | BLM | P54132 | 1/20 | 0.67 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.67 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.67 |
| ▸ | LTA4H | P09960 | 1/20 | 0.66 |
| ▸ | ACE | P12821 | 2/20 | 0.65 |
| ▸ | MME | P08473 | 1/20 | 0.63 |
| ▸ | ECE1 | P42892 | 3/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11853819 | 1.00 | KMT2A (0.67) | KMT2AKDM4EMEN1LMNAMPO | |
| SCHEMBL30625385 | 1.00 | KMT2A (0.67) | KMT2AKDM4EMEN1LMNAMPO | |
| SCHEMBL29372832 | 1.00 | KMT2A (0.67) | KMT2AKDM4EMEN1LMNAMPO | |
| SCHEMBL3361183 | 1.00 | KMT2A (0.67) | KMT2AKDM4EMEN1LMNAMPO | |
| SCHEMBL29442915 | 1.00 | KMT2A (0.67) | KMT2AKDM4EMEN1LMNAMPO | |
| SCHEMBL10448989 | 1.00 | KMT2A (0.67) | KMT2AKDM4EMEN1LMNAMPO | |
| SCHEMBL17157280 | 1.00 | KMT2A (0.67) | KMT2AKDM4EMEN1LMNAMPO | |
| SCHEMBL30052812 | 0.98 | KMT2A (0.64) | KMT2AKDM4EMEN1LMNAMPO | |
| SCHEMBL30288025 | 0.98 | KMT2A (0.64) | KMT2AKDM4EMEN1LMNAMPO | |
| SCHEMBL29578686 | 0.97 | LTA4H (0.65) | KMT2AKDM4EMEN1LMNAMPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4597111-A1 | USE OF METABOLIC MARKER FOR DIAGNOSIS OF LUNG CANCER STAGING AND KIT | Harbin Metanotitia Inc. (CN) | 2025-08-06 | — | — | EP | claimed |
| EP-3805756-A1 | SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT | Metabolon, Inc. (US) | 2021-04-14 | — | — | EP | claimed |
| CN-106537145-B | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment | 麦特博隆股份有限公司 | 2020-08-25 | — | — | CN | claimed |
| EP-3129909-A1 | SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT | Metabolon, Inc. (US) | 2017-02-15 | — | — | EP | claimed |
| WO-2015157407-A1 | SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT | METABOLON, INC. (US) | 2015-10-15 | — | — | WO | claimed |
| EP-3604503-B1 | ADDITIVE FOR UNDIFFERENTIATION MAINTAINING MEDIUM | AJINOMOTO KK (JP) | 2026-03-18 | — | — | EP | disclosed |
| US-20250270512-A1 | ADDITIVE FOR UNDIFFERENTIATION MAINTAINING MEDIUM | AJINOMOTO CO., INC. (JP) | 2025-08-28 | — | — | US | disclosed |
| EP-4597111-A1 | USE OF METABOLIC MARKER FOR DIAGNOSIS OF LUNG CANCER STAGING AND KIT | Harbin Metanotitia Inc. (CN) | 2025-08-06 | — | — | EP | disclosed |
| CN-119968127-A | Animal food compositions with improved palatability and customizable properties and methods of making the same | 玛氏公司 | 2025-05-09 | — | — | CN | disclosed |
| EP-3967217-B1 | BLOOD BASED BIOMARKERS FOR DIAGNOSING ATHEROSCLEROTIC CORONARY ARTERY DISEASE | GLOBAL GENOMICS GROUP LLC (US) | 2024-08-14 | — | — | EP | disclosed |
| US-20240230622-A9 | Methods and Systems for Determining Autism Spectrum Disorder Risk | LABORATORY CORPORATION OF AMERICA HOLDINGS (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240133865-A1 | Methods and Systems for Determining Autism Spectrum Disorder Risk | LABORATORY CORPORATION OF AMERICA HOLDINGS (US) | 2024-04-25 | — | — | US | disclosed |
| US-20150293072-A1 | METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK | LABORATORY CORPORATION OF AMERICA HOLDINGS | 2015-10-15 | — | — | US | disclosed |
| CN-102477068-B | Amino acid derivative for preparing thrombus dissolving medicament, and preparation method and application thereof | UNIV CAPITAL MEDICAL SCIENCES | 2013-07-24 | — | — | CN | disclosed |
| US-7999068-B2 | Process for the preparation of bicyclic peptide compounds | MENARINI RICERCHE S.P.A. (IT) | 2011-08-16 | — | — | US | disclosed |
| CN-1946847-A | Process for producing dipeptide | KYOWA HAKKO KOGYO KK (JP) | 2007-04-11 | — | — | CN | disclosed |
| US-5338845-A | Analgesics, antiinflammatory agent | STERLING WINTHROP INC. (US) | 1994-08-16 | — | — | US | disclosed |
| EP-0312612-B1 | NUTRITIVE EMULSION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-03-24 | — | — | EP | disclosed |
| EP-0312612-A1 | NUTRITIVE EMULSION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1989-04-26 | — | — | EP | disclosed |
| CN-1031025-A | NUTRITIVE EMULSION PREPARATION | OTSUKA PHARMA CO LTD (JP) | 1989-02-15 | — | — | CN | disclosed |